Ireland
--:--IST
Recruiting Not applicable

A Study to Assess the Clinical Success of Root Canal Treatment Using Novel Obturation Material.

NCT06312085 · tracked via the Priya Life Science Turkey tracker
Sponsor
Lumendo AG
Phase
Not applicable
Started
2024-06-07
Last updated
2024-07-12

Condition(s) studied

Endodontic Treatment

Investigational drug(s) / intervention(s)

Endofill

Endofill: Endofill is intended for the permanent obturation of root canals following root canal preparation and disinfection.

Study summary

The goal of this study is prospective, single-arm, non-randomized controlled trial to test the effectiveness, safety and performance of a novel dental obturation material. The main question sit answers is

1. To test the effectiveness of the Endofill device for root canal obturation up to 12-month follow-up period.
2. To test the performance of the Endofill device evaluated with periapical radiographs immediately on completion of procedure.

The participants requiring root canal treatment will be treated with obturated using Endofill material and post-treatment follow-up vistis will be conducted for 1 year. This is a single-arm study with no comparison groups.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria: • Patients aged 18-75 years with ASA (American Society of Anesthesiologists) classification 1 and 2. ASA 1: A normal healthy patient. Example: Fit, non-obese BMI (Body Mass Index) under 30, a non-smoking patient with good exercise tolerance. ASA 2: A patient with mild systemic disease. Example: Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker, or cigarette smoker). * Patients who agreed to participate and who have signed the informed consent. * Patients presenting with symptomatic and/or asymptomatic apical periodontitis and radiographic evidence of apical periodontitis in anterior or posterior teeth larger than 1.5 mm in diameter. * Mature tooth with closed apices. * Tooth that has never been treated with root canal therapy. Exclusion Criteria: * Patients who have pre-existing health or oral conditions that placed them at risk during the trial. * Patients with generalized untreated periodontal disease. * Patients with a history of analgesic intake within the past 3 days or antibiotics in the last 1 month. * Uncooperative patients. * Teeth with immature apices, root resorption, or requiring extensive prosthetic rehabilitation. * Teeth that cannot be made functional nor restored or difficult to access teeth with no importance (wisdom teeth). * Teeth with insufficient periodontal support. * Teeth with poor prognosis for root canal treatment, for example due to deep root caries, large root resorption or open apex cases. * Fractured teeth * Local anatomical factors such as an inaccessible root end * Presence of fractured instrument in the root canal * Pregnant women * Patients unable to understand the study procedure.

Primary outcome measure(s)

  • Effectiveness of root canal treatment using Endofill — 12 months
    To measure effectiveness by assessing overall healing, through rate of reduction in apical periodontitis, from baseline up to 12 months post-procedure by measuring periapical radiolucency size.

Trial sites (1)

FacilityCityRegionStatus
Medipol University Istanbul Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06312085 on ClinicalTrials.gov ↗ ← All trials in Turkey